TALK

CRISPR and the Art of Perturbation Screening: Unbiased functional genomic screening meets the best human cellular models

Kam Dhaliwal, SVP Strategic Alliances. 2021. bit.bio talk at ELRIG CRISPR in Drug Discovery

bit.bio talk at ELRIG CRISPR in drug discovery: CRISPR perturbation screening

CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than in healthy, differentiated cells.

Listen to our talk where we present a CRISPR perturbation screening platform developed in partnership with bit.bio and Aelian Biotechnology to query biology within the context of industry-defining human iPSC derived cellular models.

It is anticipated that the platform will be able to unlock drug targets that are relevant for human disease. Creating and utilising physiological relevant, pure and consistent human cell types, with matched disease models, will facilitate the discovery and validation of novel drug targets and elucidate the mechanism of action of drugs.

Download resource

    Please complete the form below.








    Please confirm that we may add you to our mailing list, and send you our latest news and updates:
    Yes, please email me

    You can unsubscribe at any time by clicking the link in the footer of our emails. Privacy policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms apply.

    Discover more resources

    webinars

    Webinars

    posters

    Posters

    publications

    Journals

    videos

    Videos